MedTrace Logo

Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis

NCT01909037 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2015-06-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of bio-optimized curcumin(Flexofytol) during a 90-days period in knee ostearthritis patients on the serum levels of specific biomarkers of osteoarthritis and on the evaluation of pain.

Conditions

Interventions

DIETARY_SUPPLEMENT

Flexofytol (bio-optimized curcumin)

2x3 caps/day (before breakfast and in the evening) for 3 months

Sponsors & Collaborators

  • Bioxtract SA

    collaborator INDUSTRY

  • Tilman S.A.

    lead INDUSTRY

Principal Investigators

  • Caroline Castermans, MD · Citadelle Hospital of Liege

  • Yvan Dierckxsens · Tilman S.A.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01909037 on ClinicalTrials.gov